Suresh Guruswamy

701 total citations
16 papers, 608 citations indexed

About

Suresh Guruswamy is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Suresh Guruswamy has authored 16 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Pharmacology. Recurrent topics in Suresh Guruswamy's work include Estrogen and related hormone effects (5 papers), Retinoids in leukemia and cellular processes (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Suresh Guruswamy is often cited by papers focused on Estrogen and related hormone effects (5 papers), Retinoids in leukemia and cellular processes (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Suresh Guruswamy collaborates with scholars based in United States. Suresh Guruswamy's co-authors include Jeffrey E. Pessin, Ann Louise Olson, Doris M. Benbrook, Chinthalapally V. Rao, K. Darrell Berlin, Michael A. Gold, Scott Kamelle, Vernon E. Steele, Martin A. Turman and Gerard Elberg and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Suresh Guruswamy

15 papers receiving 599 citations

Peers

Countries citing papers authored by Suresh Guruswamy

Since Specialization

Citations

This map shows the geographic impact of Suresh Guruswamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Guruswamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Guruswamy more than expected).

Fields of papers citing papers by Suresh Guruswamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Guruswamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Guruswamy. The network helps show where Suresh Guruswamy may publish in the future.

Co-authorship network of co-authors of Suresh Guruswamy

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Guruswamy. A scholar is included among the top collaborators of Suresh Guruswamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Guruswamy. Suresh Guruswamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCmin/+ Mice By SHetA2 (NSC721689) without Toxicity 2013 ·Cancer Prevention Research ·Doris M. Benbrook, Suresh Guruswamy, Yuhong Wang, Zhongjie Sun, Altaf Mohammed, Yuting Zhang, Qian Li, Chinthalapally V. Rao	31
2	Abstract 954: A selective iNOS inhibitor N6-iminoethyl-lysine tetrazoleamide (NILT), suppress invasive colonic cancers and improves preventive efficacy of low-dose COX-2 inhibitor, celecoxib in F344 rats 2010 ·Cancer Research ·Naveena B. Janakiram, Malisetty V. Swamy, Jagan M.R. Patlolla, Suresh Guruswamy, Chinthalapally V. Rao	1
3	Abstract A53: Chemoprevention of colon cancer by PBIT, an iNOS-selective inhibitor, administered alone or in combination with low-doses of celecoxib, a COX-2 selective inhibitor 2010 ·Cancer Prevention Research ·Chinthalapally V. Rao, Suresh Guruswamy, Jagan M.R. Patlolla, Naveena B. Janakiram, (unknown)	1
4	Inhibition of Azoxymethane-Induced Colorectal Cancer by CP-31398, a TP53 Modulator, Alone or in Combination with Low Doses of Celecoxib in Male F344 Rats 2009 ·Cancer Research ·Chinthalapally V. Rao, Vernon E. Steele, Malisetty V. Swamy, Jagan M.R. Patlolla, Suresh Guruswamy, Levy Kopelovich	27
5	Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling 2008 ·SHILAP Revista de lepidopterología ·Suresh Guruswamy, Chinthalapally V. Rao	19
6	S‐adenosyl L‐methionine inhibits azoxymethane‐induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco‐2 cell growth in 3D culture 2007 ·International Journal of Cancer ·Suresh Guruswamy, Malisetty V. Swamy, Chang‐In Choi, Vernon E. Steele, Chinthalapally V. Rao	32
7	Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures 2007 ·Cell and Tissue Research ·Gerard Elberg, Suresh Guruswamy, (unknown), (unknown), Martin A. Turman	31
8	EP₂receptor mediates PGE₂-induced cystogenesis of human renal epithelial cells 2007 ·American Journal of Physiology-Renal Physiology ·Gerard Elberg, (unknown), (unknown), Suresh Guruswamy, Lijuan Chen, (unknown), Michael D. Chan, Martin A. Turman	38
9	The effects of licofelone, a dual lipoxygenase and cyclooxygenase inhibitor, with and without rosiglitazone in human MCF-7 and MDA-MB-231 breast cancer cells 2007 ·Journal of Clinical Oncology ·Carla Kurkjian, Naveena B. Janakiram, Suresh Guruswamy, (unknown), Howard Ozer	5
10	Retinoids Chemosensitize Ovarian Cancer Cell Lines to Cisplatin Independent of Nuclear Receptors and p53 2006 ·American Journal of Pharmacology and Toxicology ·Suresh Guruswamy, Doris M. Benbrook	2
11	Sensitization of cervical cancer cell lines to low-dose radiation by retinoic acid does not require functional p53 2005 ·Gynecologic Oncology ·Todd Tillmanns, Scott Kamelle, Suresh Guruswamy, (unknown), Teresa Rutledge, Doris M. Benbrook	6
12	Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists 2005 ·Investigational New Drugs ·Doris M. Benbrook, Scott Kamelle, Suresh Guruswamy, Stan Lightfoot, Teresa Rutledge, (unknown), Bethany N. Hannafon, S. Terence Dunn, K. Darrell Berlin	52
13	Synthesis of Flexible Sulfur-Containing Heteroarotinoids That Induce Apoptosis and Reactive Oxygen Species with Discrimination between Malignant and Benign Cells 2004 ·Journal of Medicinal Chemistry ·Shengquan Liu, (unknown), K. Darrell Berlin, (unknown), Suresh Guruswamy, David A. Brown, Ginger J. Gardner, Michael J. Birrer, Doris M. Benbrook	63
14	Effects of Retinoids on Cancerous Phenotype and Apoptosis in Organotypic Cultures of Ovarian Carcinoma 2001 ·JNCI Journal of the National Cancer Institute ·Suresh Guruswamy, Stanley Lightfoot, Michael A. Gold, Raffit Hassan, K. Darrell Berlin, (unknown), Doris M. Benbrook	68
15	Ovarian cancer metastatic to the brain: What is the optimal management? 2001 ·Journal of Surgical Oncology ·D. Scott McMeekin, Scott Kamelle, (unknown), Todd Tillmanns, (unknown), Dennis R. Scribner, Michael A. Gold, Suresh Guruswamy, Robert S. Mannel	54
16	Myocyte Enhancer Factor 2 (MEF2)-Binding Site Is Required forGLUT4 Gene Expression in Transgenic Mice 1998 ·Journal of Biological Chemistry ·(unknown), Suresh Guruswamy, (unknown), Jeffrey E. Pessin, Ann Louise Olson	178

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact